Total Debt
$88.7M
Net Debt
-$300.1M
Tarsus Pharmaceuticals, Inc. currently has $88.7M in total debt. Net debt is -$300.1M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
TARS • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.09 | 0.39 | -0.30Net Cash | 0.58 | 15.3% |
| 2025-12-31 | 0.09 | 0.42 | -0.32Net Cash | 0.56 | 16.7% |
| 2025-09-30 | 0.08 | 0.40 | -0.32Net Cash | 0.53 | 15.4% |
| 2025-06-30 | 0.07 | 0.38 | -0.31Net Cash | 0.49 | 14.6% |
| 2025-03-31 | 0.07 | 0.41 | -0.34Net Cash | 0.50 | 14.5% |
| 2024-12-31 | 0.07 | 0.29 | -0.22Net Cash | 0.38 | 19.2% |
| 2024-09-30 | 0.07 | 0.32 | -0.24Net Cash | 0.38 | 19.2% |
| 2024-06-30 | 0.07 | 0.32 | -0.25Net Cash | 0.38 | 19.2% |
| 2024-03-31 | 0.03 | 0.30 | -0.27Net Cash | 0.35 | 8.7% |
| 2023-12-31 | 0.03 | 0.23 | -0.20Net Cash | 0.27 | 11.4% |
| 2023-09-30 | 0.03 | 0.25 | -0.22Net Cash | 0.27 | 11.2% |
| 2023-06-30 | 0.03 | 0.18 | -0.15Net Cash | 0.19 | 13.3% |
| 2023-03-31 | 0.03 | 0.20 | -0.18Net Cash | 0.21 | 11.9% |
| 2022-12-31 | 0.02 | 0.22 | -0.20Net Cash | 0.23 | 8.9% |
| 2022-09-30 | 0.02 | 0.23 | -0.21Net Cash | 0.24 | 8.5% |
| 2022-06-30 | 0.02 | 0.25 | -0.23Net Cash | 0.25 | 8.0% |
| 2022-03-31 | 0.02 | 0.18 | -0.15Net Cash | 0.18 | 11.2% |
| 2021-12-31 | 0.00 | 0.17 | -0.17Net Cash | 0.18 | 1.1% |
| 2021-09-30 | 0.00 | 0.18 | -0.18Net Cash | 0.19 | 1.2% |
| 2021-06-30 | 0.00 | 0.18 | -0.17Net Cash | 0.20 | 1.1% |
| 2021-03-31 | 0.00 | 0.16 | -0.16Net Cash | 0.19 | 0.3% |
| 2020-12-31 | 0.00 | 0.17 | -0.17Net Cash | 0.17 | 0.5% |
| 2020-09-30 | 0.00 | 0.09 | -0.09Net Cash | 0.09 | 0.9% |
| 2020-06-30 | 0.00 | 0.05 | -0.05Net Cash | 0.06 | 1.5% |
| 2019-12-31 | 0.00 | 0.06 | -0.06Net Cash | 0.06 | 0.3% |